Search results
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 3 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with psoriasis will develop ...
Which Vitamins Are Good For Arthritis?
Shape via Yahoo News· 5 days agoGeorgiy Brusovanik, MD, an orthopedist and minimally invasive spine surgeon, says there are two main types of arthritis: inflammatory and...
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 3 days agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 2 days agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 20 hours agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 22 hours agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 2 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
722 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by McAdam LLC
ETF DAILY NEWS· 2 days agoMcAdam LLC purchased a new position in Amgen Inc. (NASDAQ:AMGN – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 6 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
Barrington Research Reaffirms Outperform Rating for Option Care Health (NASDAQ:OPCH)
ETF DAILY NEWS· 6 days agoBarrington Research restated their outperform rating on shares of Option Care Health (NASDAQ:OPCH –...